A protein-stabilized multifunctional theranostic nanoplatform, gadolinium oxide-gold nanoclusters hybrid (Gd 2 O 3 –AuNCs), is constructed for multimodal imaging and drug delivery. The Gd 2 O 3 –AuNCs nanohybrid is developed by integrating Gd 2 O 3 nanocrystals and gold nanoclusters into bovine serum albumin scaffold as a stabilizer. The nanohybrid exhibits favorable biocompatibility and is capable of enhancing the contrast in magnetic resonance and X-ray computed tomography imaging. Meanwhile, the integrated AuNCs component not only endows the nanohybrid to produce red fluorescence, but also sensitizes the generation of singlet oxygen ( 1 O 2 ) upon near-infrared laser stimulation at 808 nm. Bovine serum albumin surrounding the nanoparticles makes Gd 2 O 3 –AuNCs a brilliant carrier for the delivery of indocyanine green (ICG). ICG loading endows the Gd 2 O 3 –AuNCs–ICG nanocomposite with a near-infrared fluorescence imaging capability, and improves its photodynamic property and photothermal capability. Ultimately, further experiments have demonstrated that Gd 2 O 3 –AuNCs–ICG nanocomposite is a promising theranostic agent for image guided cancer therapy.
No takes yet. Share an insight, caveat, or question.
Han et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: